A 48-Month Study to Evaluate Long-Term Effectiveness of Elocta on Joint Health

计划入组 427 人 · 首次发布于 2020 年 3 月 3 日

Hyperpolarized Xenon-129 MRI: a New Multi-dimensional Biomarker to Determine Pulmonary Physiologic Responses to COPD Therapeutics

计划入组 95 人 · 首次发布于 2016 年 12 月 23 日

A Study to Evaluate the Real-world Usage and Effectiveness of Elocta and Alprolix in Patients With Haemophilia A or B

计划入组 201 人 · 首次发布于 2017 年 2 月 16 日

Gastrodia elata 20C

Gastrodia elata whole

LptA inhibitor (Basilea Pharmaceutica)

Elypta AB

Sweden

ECLYPIA

France

ELEKTA

€13.6M EU-Funded PREDI-LYNCH Project Aims to Transform Cancer Screening for Lynch Syndrome Patients

GSK's Relvar Ellipta Demonstrates Superior Asthma Control in Landmark Real-World Study

HHS Expands Medicare Price Negotiations with 15 New Drugs Including Ozempic and Trelegy Ellipta